nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—CHRM3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000224	0.000224	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000224	0.000224	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000223	0.000223	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000222	0.000222	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000221	0.000221	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000221	0.000221	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—INSR—polycystic ovary syndrome	0.000218	0.000218	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000216	0.000216	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000216	0.000216	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000216	0.000216	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000216	0.000216	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000213	0.000213	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000213	0.000213	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000213	0.000213	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PGR—polycystic ovary syndrome	0.000211	0.000211	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00021	0.00021	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00021	0.00021	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000208	0.000208	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000208	0.000208	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000207	0.000207	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000205	0.000205	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000205	0.000205	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	0.000204	0.000204	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000204	0.000204	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000204	0.000204	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000203	0.000203	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000202	0.000202	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000202	0.000202	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000202	0.000202	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PGR—polycystic ovary syndrome	0.000202	0.000202	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	0.000201	0.000201	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000201	0.000201	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.0002	0.0002	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.0002	0.0002	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000199	0.000199	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000197	0.000197	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000196	0.000196	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000196	0.000196	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000196	0.000196	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.000195	0.000195	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000195	0.000195	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000195	0.000195	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	0.000194	0.000194	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000193	0.000193	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000189	0.000189	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000189	0.000189	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000189	0.000189	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000189	0.000189	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000188	0.000188	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000188	0.000188	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000188	0.000188	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000187	0.000187	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000187	0.000187	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000187	0.000187	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000187	0.000187	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000187	0.000187	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.000186	0.000186	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000185	0.000185	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000185	0.000185	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000184	0.000184	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000184	0.000184	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000183	0.000183	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000183	0.000183	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000182	0.000182	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000181	0.000181	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000181	0.000181	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000179	0.000179	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000179	0.000179	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000178	0.000178	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000177	0.000177	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000176	0.000176	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000175	0.000175	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000174	0.000174	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000174	0.000174	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000174	0.000174	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000174	0.000174	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000174	0.000174	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000174	0.000174	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000174	0.000174	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000173	0.000173	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000173	0.000173	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000173	0.000173	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000172	0.000172	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000172	0.000172	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000172	0.000172	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000171	0.000171	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000171	0.000171	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000171	0.000171	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PRL—polycystic ovary syndrome	0.000171	0.000171	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000169	0.000169	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000166	0.000166	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000165	0.000165	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000165	0.000165	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000164	0.000164	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000164	0.000164	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PRL—polycystic ovary syndrome	0.000164	0.000164	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000163	0.000163	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000162	0.000162	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000162	0.000162	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000161	0.000161	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00016	0.00016	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00016	0.00016	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000158	0.000158	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000158	0.000158	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000155	0.000155	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000153	0.000153	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000153	0.000153	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000151	0.000151	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.000151	0.000151	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00015	0.00015	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000148	0.000148	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000148	0.000148	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000146	0.000146	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000145	0.000145	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000144	0.000144	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000144	0.000144	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000144	0.000144	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000144	0.000144	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000143	0.000143	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000143	0.000143	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000143	0.000143	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000142	0.000142	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000142	0.000142	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000142	0.000142	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000141	0.000141	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.00014	0.00014	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000137	0.000137	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000135	0.000135	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000135	0.000135	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000132	0.000132	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000132	0.000132	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000132	0.000132	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000132	0.000132	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000132	0.000132	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00013	0.00013	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00013	0.00013	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	0.000128	0.000128	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000127	0.000127	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000127	0.000127	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000126	0.000126	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000126	0.000126	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000126	0.000126	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000124	0.000124	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	0.000123	0.000123	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000123	0.000123	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000122	0.000122	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000122	0.000122	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000122	0.000122	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000121	0.000121	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000121	0.000121	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000121	0.000121	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00012	0.00012	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	0.000118	0.000118	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—LEP—polycystic ovary syndrome	0.000118	0.000118	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000117	0.000117	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000116	0.000116	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000116	0.000116	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000116	0.000116	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000115	0.000115	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000115	0.000115	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000115	0.000115	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	0.000115	0.000115	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000115	0.000115	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000115	0.000115	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000114	0.000114	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000114	0.000114	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—LEP—polycystic ovary syndrome	0.000113	0.000113	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000111	0.000111	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000111	0.000111	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	0.00011	0.00011	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00011	0.00011	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000109	0.000109	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000109	0.000109	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000109	0.000109	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000109	0.000109	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000108	0.000108	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000105	0.000105	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	0.000102	0.000102	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000101	0.000101	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—POMC—polycystic ovary syndrome	0.000101	0.000101	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000101	0.000101	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—INS—polycystic ovary syndrome	0.000101	0.000101	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000101	0.000101	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.0001	0.0001	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IGF1—polycystic ovary syndrome	9.74e-05	9.74e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AKT2—polycystic ovary syndrome	9.73e-05	9.73e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—POMC—polycystic ovary syndrome	9.69e-05	9.69e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.66e-05	9.66e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—INS—polycystic ovary syndrome	9.64e-05	9.64e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.63e-05	9.63e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.53e-05	9.53e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	9.48e-05	9.48e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	9.45e-05	9.45e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—TH—polycystic ovary syndrome	9.39e-05	9.39e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	9.36e-05	9.36e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	9.32e-05	9.32e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	9.32e-05	9.32e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.25e-05	9.25e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	9.14e-05	9.14e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.85e-05	8.85e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	8.59e-05	8.59e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	8.25e-05	8.25e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—POMC—polycystic ovary syndrome	8.14e-05	8.14e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	8.12e-05	8.12e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	8.09e-05	8.09e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—INS—polycystic ovary syndrome	8.09e-05	8.09e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	8.01e-05	8.01e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	7.95e-05	7.95e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	7.92e-05	7.92e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	7.84e-05	7.84e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	7.67e-05	7.67e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—polycystic ovary syndrome	7.45e-05	7.45e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	7.3e-05	7.3e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	7.13e-05	7.13e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	7.09e-05	7.09e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	7.07e-05	7.07e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	7e-05	7e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.92e-05	6.92e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	6.83e-05	6.83e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	6.8e-05	6.8e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	6.79e-05	6.79e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	6.77e-05	6.77e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	6.74e-05	6.74e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	6.7e-05	6.7e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	6.57e-05	6.57e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	6.56e-05	6.56e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	6.54e-05	6.54e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	6.54e-05	6.54e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	6.48e-05	6.48e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	6.48e-05	6.48e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	6.46e-05	6.46e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.36e-05	6.36e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.23e-05	6.23e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.21e-05	6.21e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.15e-05	6.15e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.09e-05	6.09e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	5.23e-05	5.23e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	5.16e-05	5.16e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—INS—polycystic ovary syndrome	5.13e-05	5.13e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	5.02e-05	5.02e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	5e-05	5e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.96e-05	4.96e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—polycystic ovary syndrome	4.4e-05	4.4e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.29e-05	4.29e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.27e-05	4.27e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.23e-05	4.23e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	4.21e-05	4.21e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	2.97e-05	2.97e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	2.96e-05	2.96e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	2.93e-05	2.93e-05	CbGpPWpGaD
